-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

331. Pathophysiology of Thrombosis: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Coronaviruses, SARS-CoV-2/COVID-19, Bleeding and Clotting, Diseases, Hemostasis, platelets, Genetic Disorders, Pediatric, Thrombosis, white blood cells, Polycythemia vera, Cell Lineage, thrombocythemia, Study Population, Thromboembolism, Clinically relevant, Myeloid Malignancies, Thrombotic Disorders, VTE
Monday, December 7, 2020: 7:00 AM-3:30 PM

Binbin Zheng, MD, MSc1, Qian Wang, MD, MPH2*, Sridevi Rajeeve, MD3, Biyue Dai, PhD4*, Cynthia Zevallos, MD4*, Darko Quispe-Orozco, MD4*, Mudassir Farooqui, MD MPH4*, Jorge Ares-Morcuende4* and Santiago Ortega-Gutierrez, MD MSc4*

1Department of Medicine, Icahn School of Medicine, Mount Sinai Morning and Mount Sinai West, NEW YORK, NY
2Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
3Division of Hematology and Oncology - Department of Medicine, Icahn School of Medicine At Mount Sinai Hospital, New York, NY
4Department of Neurology, Carver College of Medicine, Iowa City, IA

Mackenzie Parker, BS1*, Ayesha Zia2, Tony Babb, Ph.D.1* and Michael D. Nelson, Ph.D.1*

1University of Texas Southwestern Medical Center, Dallas, TX
2University of Southwestern Medical Center, Dallas, TX

Elena Monzón Manzano1*, Ihosvany Fernandez-Bello, BSPharm, PhD2*, Raul Justo Sanz2*, Ángel Robles Marhuenda3*, Paula Acuña2*, María Teresa Alvarez Román, MD, PhD4*, Elena G Arias-Salgado, PhD5*, Sara García Barcenilla5*, Miguel A Canales, MD, PhD4,6, Victor Jimenez-Yuste, Medical Degree. PhD5,6* and Nora V. Butta, PhD4*

1Hospital Universitario La Paz-IdiPaz, Madrid, Spain
2Hospital Universitario La Paz-Idipaz, Madrid, Spain
3Internal Medicine Unit, Hospital Universitario La Paz, Madrid, Spain
4Hematology and Hemotherapy Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
5Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
6Universidad Autónoma de Madrid, Madrid, Spain

Jihyun Song, PhD1, Adelina Sergueeva, MD2*, Galina Miasnikova, MD3*, Soo Jin Kim, MS4*, Binal N. Shah, PhD5*, Tsewang Tashi, MD4, Xu Zhang, PhD6*, Perumal Thiagarajan, MD7, Victor R. Gordeuk, MD8 and Josef T. Prchal, MD4

1Division of Hematology, University of Utah, Salt Lake City, UT
2I. N. Ulianov Chuvash State University, Cheboksary, Russian Federation
3Chuvash Republic Clinical Hospital, Cheboksary, Russian Federation
4Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
5Department of Medicine, University of Illinois At Chicago, Chicago, IL
6University of Illinois At Chicago, Chicago, IL
7Michael E DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX
8Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL

Damian Ratano, MD1*, Caragata Rebecca, MD2*, Eddy Fan, MD, PhD, FRCPC1*, Ewan C Goligher, MD, PhD, FRCPC1*, Rita Selby, MBBS, FRCPC3,4, Niall D Ferguson, MD, FRCPC1*, Keyvan Karkouti, MD, MSc, FRCPC5* and Stuart A McCluskey, MD, PhD, FRCPC2*

1Department of Medicine, Interdepartmental Division of Critical Care Medicine, University Health Network, University of Toronto, Toronto, ON, Canada
2Department of Anesthesia and Pain Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada
3Laboratory Medicine and Medicine, University Health Network and Sunnybrook Health Sciences Centre, Toronto, ON, Canada
4Department of Medicine, Division of Hematology, University of Toronto, Toronto, Canada
5Department of Anesthesiology and Pain Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

Jihyun Song, PhD1, Jahnavi Gollamudi, MD2, Soo Jin Kim, MS3*, Radhika Gangaraju, MD4, Tsewang Tashi, MD3, Victor R. Gordeuk, MD5, Perumal Thiagarajan, MD6 and Josef T. Prchal, MD7

1Division of Hematology,, University of Utah, Salt Lake City, UT
2Department of Pathology and Medicine, Baylor College of Medicine, Houston, TX
3Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
4Division of Hematology and Oncology, Department of Medicine, University Of Alabama at Birmingham, Birmingham, AL
5Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
6Michael E DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX
7Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT

Thomas Bertsch1*, Wilhelm Behringer2*, Sabine Blaschke3*, Richard Body4*, Simon Davidson5*, Anna Rieger6*, Daniel Horner7*, Ulrich Sonner8*, Yuli Sun6*, Lucia Turnes8* and Michael Hoffman6*

1Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Paracelsus Medical University, Nuremberg, Germany
2Centre of Emergency Medicine, Jena University Hospital, Jena, Germany
3Interdisciplinary Emergency Care Department, University Medical Center Göttingen, Göttingen, Germany
4Central Manchester NHS Foundation Trust, Manchester, United Kingdom
5Roche Diagnostics International Ltd, Rotkreuz, Switzerland
6Roche Diagnostics GmbH, Penzberg, Germany
7Salford Royal NHS Foundation Trust, Salford, United Kingdom
8Agent representing Roche Diagnostics GmbH, Penzberg, Germany

*signifies non-member of ASH